References
Garrod, A. E. 1908. Inborn errors of metabolism. Lancet 2:1–7.
Popjak, G. 1975. Role of biochemistry in research on mental retardation. Pages 507–516,in Buchwald, N. A., and Brazier, M. A. B. (eds.), Brain Mechanisms in Mental Retardation, Academic Press, New York.
Brady, R. O. 1976. Inherited metabolic diseases of the nervous system. Science 193:733–739.
Scriver, C. R. 1969. Inborn errors of amino acid metabolism. Br. Med. Bull. 25:35–41.
Nyhan, W. L. 1974. Heritable Disorders of Amino Acid Metabolism: Patterns of Clinical Expression and Genetic Variation, John Wiley, New York.
Wiltse, H. E., andMenkes, J. H 1972. Brain damage in the aminoacidurias. Pages 143–167,in Lajtha, A. (ed.), Handbook of Neurochemistry, Vol. VII, Pathological Chemistry of the Nervous System, Plenum Press, New York.
Gaull, G. E. 1972. Abnormal metabolism of sulfur-containing amino acids associated with brain dysfunction. Pages 169–190,in Lajtha, A. (ed.), Handbook of Neurochemistry, Vol. VII, Pathological Chemistry of the Nervous System, Plenum Press, New York.
Guroff, G., King, W., andUdenfriend, S. 1961. The uptake of tyrosine by rat brain in vitro. J. Biol. Chem. 236:1773–1777.
Appel, S. H. 1966. Inhibition of brain protein synthesis: An approach to the biochemical basis of neurological dysfunction in the aminoacidurias. Trans. N.Y. Acad. Sci. 29:63–69.
Appel, S. H. 1970. Inhibition of brain protein synthesis. Pages 621–630,in Lajtha, A. (ed.), Protein Metabolism of the Nervous System, Plenum Press, New York.
Hughes, J. V., andJohnson, T. C. 1976. The effects of phenylalanine on amino acid metabolism and protein synthesis in brain cells in vitro. J. Neurochem. 26:1105–1113.
Fellman, J. H. 1956. Inhibition of DOPA decarboxylase by aromatic acids associated with phenylpyruvic oligophrenia. Proc. Soc. Exp. Biol. Med. 93:413–414.
Hanson, A. 1959. Action of phenylalanine metabolites on glutamic acid decarboxylase and γ-amino butyric acid-α-ketoglutaric acid transaminase in brain. Acta Chem. Scand. 13:1366–1374.
Tashian, R. E. 1961. Inhibition of brain glutamic acid decarboxylase by phenylalanine, valine and leucine derivatives: A suggestion concerning the etiology of the neurological defect in phenylketonuria and branched-chain ketonuria. Metabolism 10:393–402.
Yuwiler, A., andGeller, E. 1969. Brain serotonin changes in phenylalanine-fed rats: Synthesis, storage and degradation. J. Neurochem. 16:999–1005.
Shah, S. N., Peterson, N. A., andMcKean, C. M. 1972. Impaired myelin formation in experimental hyperphenylalaninaemia. J. Neurochem. 19:479–485.
Menkes, J. H. 1968. Cerebral proteolipids in phenylketonuria. Neurology 18:1003–1008.
Menkes, J. H., Hurst, P. L., andCraig, J. M. 1954. A new syndrome: Progressive familial cerebral dysfunction with an unusual urinary substance. Pediatrics 14:462–466.
Dancis, J., Hutzler, J., andLevitz, M. 1963. The diagnosis of maple syrup urine disease (branched chain ketoaciduria) by the in vitro study of the peripheral leukocyte. Pediatrics 32:234–238.
Dancis, J., Hutzler, J., andLevitz, M. 1965. Detection of the heterozygote in maple syrup urine disease. J. Pediatr. 66:595–603.
Dancis, J., Hutzler, J., andCox, R. P. 1969. Enzyme defect in skin fibroblasts in intermittent branched-chain ketonuria and in maple syrup urine disease. Biochem. Med. 2:407–411.
Menkes, J. H., Philippart, M. andFiol, R. E. 1965. Cerebral lipids in maple syrup disease. J. Pediatr. 66:584–594.
Prensky, A. L., andMoser, H. W., 1966. Brain lipids, proteolipids, and free amino acids in maple syrup urine disease. J. Neurochem. 13:863–874.
Menkes, J. H., andSolcher, H., 1967. Maple syrup urine disease: Effects of dietary therapy on cerebral lipids. Arch. Neurol. 16:486–491.
Ladu, B. N., Howell, R. R., Jacoby, G. A., Seegmiller, J. E., andZanroni, V. G. 1962. The enzymatic defect in histidinemia. Biochem. Biophys. Res. Commun. 7:398–402.
Ladu, B. N., Howell, R. R., Jacoby, G. A., Seegmiller, J. E., Sober, E. K., Zanroni, V. G., Canby, J. P., andZiegler, L. K. 1963. Clinical and biochemical studies on two cases of histidinemia. Pediatrics 32:216–227.
Woody, N. C., Snyder, C. H., andHarris, J. A. 1965. Histidinemia. Am. J. Dis. Child. 110:606–613.
Ladu, B. N. 1972. Histidinemia. Pages 338–350,in Stanbury, J. B., Wyngaarden, J. B., and Fredrickson, D. S. (eds.), The Metabolic Basis of Inherited Disease, McGraw-Hill, New York.
Woody, N. C. 1964. Hyperlysinemia. Am. J. Dis. Child. 108:543–553.
Ghadimi, H., Binnington, V. I., andPecora, P. 1965. Hyperlysinemia associated with retardation. N. Engl. J. Med. 273:723–729.
Armstrong, M. D., andRobinow, M. 1967. A case of hyperlysinemia: Biochemical and clinical observations. Pediatrics 39:546–554.
Gerritsen, T., andWaisman, H. A. 1972. Homocystinuria Pages 404–412,in Stanbury, J. B., Wyngaarden, J. B., and Fredrickson, D. S., (eds.), The Metabolic Basis of Inherited Disease, McGraw-Hill, New York.
Mudd, S. H., Finkelstein, J. D., Irreverre, F., andLaster, L., 1964. Homocystinuria; an enzymatic defect. Science 143:1443–1445.
Carson, N. A. J., andCarre, I. J. 1969. Treatment of homocystinuria with pyridoxine; a preliminary study. Arch. Dis Child. 44:387–392.
Folling, A. 1934. Über Ausscheidung von phenylbrenztraubensäure in den Harn als Stoffwechselanomalie in Verbindung mit Imbezillität. Hoppe-Seyler's Physiol. Chem. 227:169–176.
Knox, W. E. 1972. Phenylketonuria. Pages 266–295,in Stanbury, J. B., Wyngaarden, J. B., and Fredrickson, D. S. (eds.), The Metabolic Basis of Inherited Disease. McGraw-Hill, New York.
Koch, R., Blaskovics, M., Wenz, E., Fishler, K., andSchaeffler, G. 1974. Phenylalaninemia and phenylketonuria, pages 109–140,in Nyhan, W. L. (ed.), Heritable Disorders of Amino Acid Metabolism: Pattern of Clinical Expression and Genetic Variation, John Wiley, New York.
Scriver, C. R., andRosenberg, L. E. 1973. Phenylalanine. Pages 290–337,in Scriver, C. R., and Rosenberg, L. E. (eds.) Amino Acid Metabolism and Disorders, W. B. Saunders, Philadelphia.
Jervis, G. A. 1939. The genetics of phenylpyruvic oligophrenia. J. Ment. Sci. 85:719–725.
Jervis, G. A., Block, R. J., Bolling, D., andKanze, E. 1940. Phenylalanine content of blood and spinal fluid in phenylpyruvic oligophrenia. J. Biol. Chem. 134:105–113.
Jervis, G. A. 1947. Studies of phenylpyruvic oligophrenia: The position of the metabolic error. J. Biol. Chem. 169:651–656.
Jervis, G. A. 1953. Phenylpyruvic oligophrenia: Deficiency of phenylalanine-oxidizing system. Proc. Soc. Exp. Biol. Med. 82:514–515.
Mitoma, C., Auld, R. M., andUdenfriend, S.1957. On the nature of enzymic defect in phenylpyruvic oligophrenia. Proc. Soc. Exp. Biol. Med. 94:634–635.
Wallace, H. W., Moldave, K., andMeister, A.1957. Studies on conversion of phenylalanine to tyrosine in phenylpyruvic oligophrenia. Proc. Soc. Exp. Biol. Med. 94:632–633.
Kaufman, S. 1958. Phenylalanine hydroxylation cofactor in phenylketonuria. Science 128:1506–1508.
Friedman, P. A., Fisher, D. B., Kang, E. S., andKaufman, S. 1973. Detection of hepatic phenylalanine 4-hydroxylase in classical phenylketonuria. Proc. Natl. Acad. Sci. U.S.A. 70:552–556.
Kaufman, S. 1971. The phenylalanine hydroxylating system from mammalian liver. Adv. Enzymol. 35:245–319.
Barranger, J. A., Geiger, P. J., Huzino, A., andBessman, S. P. 1972. Isozymes of phenylalanine hydroxylase. Science 175:903–905.
Levy, H. L., Karolkewicz, V., Houghton, S. A., andMaccready, R. A. 1970. Screening the normal population in Massachusetts for phenylketonuria. N. Engl. J. Med. 282:1455–1458.
Linneweh, F., andEhrlich, M. 1960. Die renalen und prärenalen störugen des aminosäuren-stoffwechsels bei phenylalaninarmer ernährung. Klin. Wochenschr. 38:904–910.
Linneweh, F., andEhrlich, M. 1962. Zur pathogenese des schwachsinns bei phenylketonurie. Klin. Wochenschr. 40:225–226.
Pare, C. M., Sandler, M., andStacey, R. S. 1957. 5-Hydroxytryptamine deficiency in phenylketonuria. Lancet 1:551–553.
Boylen, J. B., andQuastel, J. H. 1962. Effects ofl-phenylalanine and sodium phenylpyruvate on the formation of melanin froml-tryosine in melanoma. Nature (London) 193:376–377.
Shah, S. N., Peterson, N. A., andMcKean, C. M. 1972. Lipid composition of human cerebral white matter and myelin in phenylketonuria. J. Neurochem. 19:2369–2376.
Lipton, M. A., Gordon, R., Guroff, G., andUdenfriend, S. 1967.p-Chlorophenylalanine-induced chemical manifestations of phenylketonuria in rats. Science 156:248–250.
Greengard, O., Yoss, M. S., andDelvalle, J. A. 1976. α-Methylphenylalanine, a new inducer of chronic hyperphenylalaninemia in suckling rats. Science 192:1007–1008.
Gal, E. M., Roggeveen, A. E., andMillard, S. A. 1970.d, l[2-14C]p-Chlorophenylalanine as an inhibitor of tryptophan 5-hydroxylase. J. Neurochem. 17:1221–1235.
Weber, G. 1969. Inhibition of human brain pyruvate kinase and hexokinase by phenylalanine and phenylpyruvate: possible relevance to phenylketonuric brain damage. Proc. Natl. Acad. Sci. U.S.A. 63:1365–1369.
Shah, S. N., Peterson, N. A. andMcKean, C. M. 1969. Inhibition of sterol synthesis in vitro by metabolites of phenylalanine. Biochim. Biophys. Acta 187:236–242.
Silberberg, D. H. 1967. Phenylketonuria metabolites in cerebellum culture morphology. Arch. Neurol. 17:524–529.
Loo, Y. H., andRitman, P. 1964. New metabolites of phenylalanine. Nature (London) 203:1237–1239.
Loo, Y. H. 1967. Characterization of a new phenylalanine metabolite in phenylketonuria. J. Neurochem. 14:813–821.
Kurtz, D. J., Levy, H., andKanfer, J. N. 1972. Cerebral lipids and amino acids in the vitamin B6-deficient suckling rat. J. Nutr. 102:291–298.
Loo, Y. H., andMack, K. 1972. Effect of hyperphenylalaninemia on vitamin B6 metabolism in developing rat brain. J. Neurochem. 19:2377–2383.
Holtz, P., Credner, K., andHeppe, F. 1947. Über die beeinflussung der diurese durch oxytyramin und andere sympathicomimetische amine. Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmakol. 204:85–97.
Edwards, D. J., andBlau, K. 1973. Phenethylamines in brain and liver of rats with experimentally induced phenylketonuria-like characteristics. Biochem. J. 132:95–100.
McKean, C. M. 1972. The effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain. Brain Res. 47:469–476.
McKean, C. M., Boggs, D. E. andPeterson, N. A. 1968. The influence of high phenylalanine and tryosine on the concentrations of essential amino acids in brain. J. Neurochem. 15:235–241.
Aoki, K. andSiegel, F. L. 1970. Hyperphenylalaninemia: Disaggregation of brain polyribosomes in young rats. Science 168:129–130.
Gal, E. M., Armstrong, J. C., andGinsberg, B. 1966. The nature of in vitro hydroxylation ofl-tryptophan by brain tissue. J. Neurochem. 13:643–654.
Loo, Y. H. 1974. Serotonin deficiency in experimental hyperphenylalaninemia. J. Neurochem. 23:139–147.
Weil-Malherbe, H. 1955. The concentration of adrenaline in human plasma and its relation to mental activity. J. Ment. Sci. 101:733–755.
Boylen, J. B., andQuastel, J. H. 1961. Effects ofl-phenylalanine and sodium phenylpyruvate on the formation of adrenaline froml-tyrosine in adrenal medulla in vitro. Biochem. J. 80:644–648.
Fellman, J. H., andDevlin, M. K. 1958. Concentration and hydroxylation of free phenylalanine in adrenal glands. Biochim. Biophys. Acta 28:328–332.
Cawte, J. E. 1957. Attempt to determine reaction to adrenaline in phenylketonuria. J. Ment. Defic. Res. 1:111–117.
Glazer, R. I., andWeber, G. 1971. The effects ofl-phenylalanine and phenylpyruvate on glycolysis in rat cerebral cortex. Brain Res. 33:439–450.
Miller, A. L., Hawkins, R. A., andVeech, R. L. 1973. Phenylketonuria: phenylalanine inhibits brain pyruvate kinase in vivo. Science 179:904–905.
Christensen, H. N. 1953. Metabolism of amino acids and proteins. Annu. Rev. Biochem. 22:233–260.
McKean, C. M., andPeterson, N. A. 1970. Glutamine in the phenylketonuric central nervous system. N. Engl. J. Med. 283:1364–1367.
Guroff, G., andUdenfriend, S. 1962. Studies on aromatic acid uptake by rat brain in vivo. J. Biol. Chem. 237:803–806.
Agrawal, H. C., Bone, A. H., andDavison, A. N. 1970. Effect of phenylalanine on protein synthesis in the developing rat brain. Biochem. J. 117:325–331.
Vahvelainen, M. L., andOja, S. S. 1975. Kinetic analysis of phenylalanine-induced inhibition in the saturable influx of tyrosine, tryptophan, leucine and histidine into brain cortex slices from adult and 7-day-old rats. J. Neurochem. 24:885–892.
Boggs, D. E., Deropp, R. S., andMcKean, C. M. 1964. The effects of high circulating phenylalanine on brain amino acids. Fed. Proc. 23:146.
O'Brien, D., andIbbot, F. Z. 1966. Effect of prolonged phenylalanine loading on the free amino-acid and lipid content of the infant monkey brain. Dev. Med. Child. Neurol. 8:724–728.
Richter, J. J., andWainer, A. 1971. Evidence for separate systems for the transport of neutral and basic amino acids across the blood-brain barrier. J. Neurochem. 18:613–620.
Alford, E. C., Stevenson, L. D., Vogel, F. S., andEngle, R. L. 1950. Neuropathological findings in phenyl-pyruvic oligophrenia (phenylketonuria). J. Neuropathol. Exp. Neurol. 9:298–310.
Prensky, A. L., Fishman, M. A., andDaftari, B. 1971. Differential effects of hyperphenylalaninemia on the development of the brain in the rat. Brain Res. 33:181–191.
Lindroos, O. F. C., andOja, S. S. 1971. Hyperphenylalaninemia and the exchange of tyrosine in adult rat brain. Exp. Brain Res. 14:48–60.
Swaiman, K. F., Hosfield, W. B. andLemieux, B. 1968. Elevated plasma phenylalanine concentration and lysine incorporation into ribosomal protein of developing brain. J. Neurochem. 15:687–690.
Antonas, K. N., andCoulson, W. F. 1975. Brain uptake and protein incorporation of amino acids studied in rats subjected to prolonged hyperphenylalaninemia. J. Neurochem. 25:309–314.
Peterson, N. A. andMcKean, C. M. 1969. The effects of individual amino acids on the incorporation of labelled amino acids into proteins by brain homogenates. J. Neurochem. 16:1211–1217.
Oja, S. S. 1972. Incorporation of phenylalanine, tryosine and tryptophan into protein of homogenates from developing rat brain: Kinetics of incorporation and reciprocal inhibition. J. Neurochem. 19:2057–2069.
Siegel, F. L., Aoki, K., andColwell, R. E. 1971. Polyribosome diaggregation and cell-free protein synthesis in preparations from cerebral cortex of hyperphenylalaninemic rats. J. Neurochem. 18:537–547.
Macinnes, J. W., andSchlesinger, K. 1971. Effects of excess phenylalanine on in vitro and in vivo RNA and protein synthesis and polyribosome levels in brains of mice. Brain Res. 29:101–110.
Roscoe, J. P., Eaton, M. D., andChoy, G. C. 1968. Inhibition of protein synthesis in Krebs 2 ascites cells and cell-free systems by phenylalanine and its effect on leucine and lysine in the amino acid pool. Biochem. J. 109:507–515.
Taub, F., andJohnson, T. C. 1975. The mechanism of polyribosome disaggregation in brain tissue by phenylalanine. Biochem. J. 151:173–180.
Copenhaver, J. H., Vacanti, J. P., andCarver, M. J. 1973. Experimental maternal hyperphenylalaninemia: Disaggregation of fetal brain ribosomes. J. Neurochem. 21:273–280.
Roberts, S., andMorelos, B. S. 1976. Role of ribonuclease action in phenylalanine-induced disaggregation of rat cerebral polyribosomes. J. Neurochem. 26:387–400.
Belitsina, N. V., andSpirin, A. S. 1970. Studies on the structure of ribosomes. IV. participation of aminoacyl-transfer RNA and peptidyl-transfer RNA in the association of ribosomal subparticles. J. Mol. Biol. 52:45–55.
Mathews, R. A., andWettstein, F. O. 1974. Differences in the subunit exchange between native and runoff single ribosomes. Biochim. Biophys. Acta 366:300–309.
Hughes, J. V., andJohnson, T. C. 1977. The effects of hyperphenylalaninemia on the concentrations of aminoacyl-transfer ribonucleic acid in vivo: A mechanism for the inhibition of neural protein synthesis by phenylalanine. Biochem. J. 162:527–537.
Hughes, J. V., andJohnson, T. C. 1978. Experimentally-induced and natural recovery from the effects of phenylalanine on brain protein synthesis. Biochim. Biophys. Acta 517:473–485.
Hughes, J. V., andJohnson, T. C. 1977. Hyperphenylalanemia: Effect on brain polyribosomes can be partially reversed by other amino acids. Science 195:402–404.
Dunlop, D. S., Van Elden, W., andLajtha, A. 1975. A Method for measuring brain protein synthesis rates in young and adult rats. J. Neurochem. 24:337–344.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hughes, J.V., Johnson, T.C. Abnormal amino acid metabolism and brain protein synthesis during neural development. Neurochem Res 3, 381–399 (1978). https://doi.org/10.1007/BF00966321
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00966321